European Archives - Page 149 of 1170 - European Medical Journal

Sugary Drinks May Increase Diabetes Risk via Gut Microbiome

Researchers have shown that sugary drink intake affects diabetes risk via gut microbiome.

NICE Endorses First-of-Its-Kind Allergic Rhinitis Treatment

The newly recommended immunotherapy works by gradually increasing the body’s resistance to house dust mites.

EMJ Innovations 9 [Supplement 1] 2025

In this symposium, three case studies from the UK and Spain demonstrated how fewer appointments per patient with faricimab resulted in…

Reverse Clinical Signs of Ageing
with Epigenetic Skin Science

Join leading dermatologists and epigenetics researchers Frank Lyko, Firas Al-Niaimi, Hassan Galadari, Elke Grönniger, and Julia Gallinger…

Lungs

Qureight and Avalyn unite to advance pulmonary fibrosis treatment

Two companies have come together to enhance the way imaging technology is used to assess treatment responses in progressive pulmonary fibrosis.

New Risk Score Uses Stress Levels to Improve Heart Disease Prediction

A novel cardiovascular risk score improves prediction of heart disease by assessing stress-related changes in vascular function.

Optic Neuropathy Concerns with Popular Antidiabetic Drugs

Ophthalmic complications linked to semaglutide and tirzepatide raise concerns for diabetic patients on these medications.

Joint-Specific Responses to TNFi in Psoriatic Arthritis Revealed in European Study

A study of over 1,700 psoriatic arthritis patients across nine European countries reveals that tumor necrosis factor inhibitors (TNFi) work differently depending on the affected joint.

Understanding Biological Mechanisms Behind Postpartum Depression

One promising area of research revolves around neuroactive steroids (NAS), which are metabolites of cholesterol that can influence brain activity.

Overexpression of RAD51 Family Genes Linked to Poorer Breast Cancer Prognosis

Overexpression of RAD51 genes correlates with poorer prognosis in breast cancer, highlighting its potential as a prognostic biomarker and therapeutic target.